aRagon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Boston, MA, USA
bDepartment of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, Australia
cKwaZulu-Natal Research Institute for TB and HIV
dHIV Pathogenesis Programme, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal
eBiostatistics Unit, Medical Research Council, Durban, South Africa
fDepartment of Paediatrics, University of Oxford, Oxford OX1 3SY, UK
gMax Planck Institute for Infection Biology, Charitéplatz 1, 10117 Berlin, Germany.
Correspondence to Thumbi Ndung’u, KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH), University of KwaZulu-Natal, 719 Umbilo Road, Durban 4013, South Africa. Tel: +27 31 260 4727; fax: +27 31 260 4623; e-mail: [email protected]
Received 16 October, 2017
Revised 19 January, 2018
Accepted 22 January, 2018
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (http://www.AIDSonline.com).